Abraham Tomco
Family Medicine · Orem, UTNPI 1033320791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 29.9% of the total. Reporting peaked in 2021 at $672 and has fallen 97.7% since, to $16 in 2025.
Across 108 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$531
- Amgen$196
- Sanofi-aventis U.S. LLC$115
- Lilly USA, LLC$113
- Biohaven Pharmaceuticals, Inc.$96
- AstraZeneca$91
- plus $633 from 23 others
What the payments were for
- Food & beverage$1,76299%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $531 |
| Amgen(2 entities) | 13 | $196 |
| Sanofi-aventis U.S. LLC | 8 | $115 |
| Lilly USA, LLC | 8 | $113 |
| Biohaven Pharmaceuticals, Inc. | 6 | $96 |
| AstraZeneca | 7 | $91 |
| Pfizer | 6 | $81 |
| Astellas Pharma US Inc | 3 | $44 |
| Endo Pharmaceuticals Inc. | 3 | $42 |
| Merck | 3 | $42 |
| Cranial Technologies, Inc | 2 | $39 |
| Nevro Corp. | 1 | $38 |
| Eisai Inc. | 3 | $36 |
| Neurocrine Biosciences, Inc. | 2 | $32 |
| Almatica Pharma LLC | 1 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Abbott | 2 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| Mylan Specialty L.p. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Neurelis, Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $12 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
How this compares
$1,774 in reported general payments places this provider in the 70th percentile of 928 family medicine providers in Utah.
Other family medicine in Orem
- Jeremy ReidOrem$8K
- Michael CobbleSandy$1.3M
- Thomas ClarkProvidence$332K
- Courtney NelsonLayton$190K
- David ButtersLayton$189K
- Scott EricksonBountiful$101K
- Mark CacciamaniSalt Lake City$43K
- Clint MowerLehi$41K
- Russell AndersonTooele$30K
- Kirk OdonnellSalt Lake City$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.